Racial disparities in histopathologic characteristics of uterine cancer are present in older, not younger blacks in an equal-access environment

Gynecologic Oncology

Volumn 123, Issue 1, 2011, Pages 76-81

  Oliver, Kate E ^a   Enewold, Lindsey R ^a   Zhu, Kangmin ^a,b   Conrads, Thomas P ^c   Rose, G Scott ^a   Maxwell, G Larry ^a   Farley, John H ^d  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^c BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Age; Disparity; Racial; Uterine cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; FEMALE; GROUPS BY AGE; HEALTH CARE ACCESS; HEALTH DISPARITY; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RACISM; TUMOR DIFFERENTIATION; UTERUS CANCER; UTERUS TUMOR;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; CARCINOMA, ENDOMETRIOID; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; MIDDLE AGED; REGISTRIES; UNITED STATES; UTERINE NEOPLASMS;

EID: 80052566068     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.06.027     Document Type: Article

References (49)

1. American Cancer Society Cancer facts & figures 2010 American Cancer Society Atlanta
2. National Cancer Institute's Surveillance Epidemiology and End Results Cancer Statistics SEER 17 data [cited 2010 October]; Available from http://seer.cancer.gov/statfacts/html/corp.html 2010
3. S.L. Clifford, C.P. Kaminetsky, F.D. Cirisano, R. Dodge, J.T. Soper, and D.L. Clarke-Pearson Racial disparity in overexpression of the p53 tumor suppressor gene in stage I endometrial cancer Am J Obstet Gynecol 176 6 Jun. 1997 S229 S232
4. National Cancer Institute's Surveillance Epidemiology and End Results SEER 9 data Fast Stats [cited 2010 October]; Available from http://seer.cancer. gov/faststats/selections.php 2010
5. H. Aziz, F. Hussain, S. Edelman, J. Cirrone, I. Aral, and R. Fruchter Age and race as prognostic factors in endometrial carcinoma Am J Clin Oncol 19 6 Dec. 1996 595 600 (Pubitemid 26384711)
6. R.J. Barrett 2nd, L.C. Harlan, M.N. Wesley, H.A. Hill, V.W. Chen, and L.A. Clayton Endometrial cancer: stage at diagnosis and associated factors in black and white patients Am J Obstet Gynecol 173 2 Aug. 1995 414 422 discussion 22-3
7. P.P. Connell, J. Rotmensch, S.E. Waggoner, and A.J. Mundt Race and clinical outcome in endometrial carcinoma Obstet Gynecol 94 5 Pt 1 Nov. 1999 713 720 (Pubitemid 29484437)
8. L.S. Cook, L.M. Kmet, A.M. Magliocco, and N.S. Weiss Endometrial cancer survival among U.S. black and white women by birth cohort Epidemiology 17 4 Jul. 2006 469 472 (Pubitemid 44305521)
9. M.L. Hicks, J.L. Phillips, G. Parham, N. Andrews, W.B. Jones, and H.M. Shingleton The National Cancer Data Base report on endometrial carcinoma in African-American women Cancer 83 12 Dec. 15 1998 2629 2637 (Pubitemid 29019585)
10. H.A. Hill, R.J. Coates, H. Austin, P. Correa, S.J. Robboy, and V. Chen Racial differences in tumor grade among women with endometrial cancer Gynecol Oncol 56 2 Feb. 1995 154 163
11. C.L. Kosary FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina Semin Surg Oncol 10 1 Jan-Feb. 1994 31 46
12. J.R. Liu, M. Conaway, G.C. Rodriguez, J.T. Soper, D.L. Clarke-Pearson, and A. Berchuck Relationship between race and interval to treatment in endometrial cancer Obstet Gynecol 86 4 Pt 1 Oct. 1995 486 490
13. T. Madison, D. Schottenfeld, S.A. James, A.G. Schwartz, and S.B. Gruber Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival Am J Public Health 94 12 Dec. 2004 2104 2111 (Pubitemid 39578414)
14. G.L. Maxwell, J.I. Risinger, K.A. Hayes, A.A. Alvarez, R.K. Dodge, and J.C. Barrett Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers Clin Cancer Res 6 8 Aug. 2000 2999 3005 (Pubitemid 30637721)
15. G.L. Maxwell, and J.I. Risinger Racial disparities research: it's not just black and white Gynecol Oncol 101 2 May 2006 194 197
16. G.L. Maxwell, C. Tian, J.I. Risinger, C.A. Hamilton, and R.R. Barakat Racial disparities in recurrence among patients with early-stage endometrial cancer: is recurrence increased in black patients who receive estrogen replacement therapy? Cancer 113 6 Sep. 15 2008 1431 1437
17. T.C. Randall, and K. Armstrong Differences in treatment and outcome between African-American and white women with endometrial cancer J Clin Oncol 21 22 Nov. 15 2003 4200 4206 (Pubitemid 46606189)
18. V.L. Schimp, R. Ali-Fehmi, L.A. Solomon, A. Hammoud, V. Pansare, and R.T. Morris The racial disparity in outcomes in endometrial cancer: could this be explained on a molecular level? Gynecol Oncol 102 3 Sep. 2006 440 446 (Pubitemid 44354952)
19. V.W. Setiawan, M.C. Pike, L.N. Kolonel, A.M. Nomura, M.T. Goodman, and B.E. Henderson Racial/ethnic differences in endometrial cancer risk: the multiethnic cohort study Am J Epidemiol 165 3 Feb. 1 2007 262 270 (Pubitemid 46178272)
20. S.C. Steinhorn, M.H. Myers, B.F. Hankey, and V.F. Pelham Factors associated with survival differences between black women and white women with cancer of the uterine corpus Am J Epidemiol 124 1 Jul. 1986 85 93 (Pubitemid 16095838)
21. J.D. Wright, J. Fiorelli, P.B. Schiff, W.M. Burke, A.L. Kansler, and C.J. Cohen Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time Cancer 115 6 Mar. 15 2009 1276 1285
22. J.E. Allard, and G.L. Maxwell Race disparities between black and white women in the incidence, treatment, and prognosis of endometrial cancer Cancer Control 16 1 Jan. 2009 53 56
23. J. Farley, J.I. Risinger, G.S. Rose, and G.L. Maxwell Racial disparities in blacks with gynecologic cancers Cancer 110 2 Jul. 15 2007 234 243 (Pubitemid 47121882)
24. G.L. Maxwell, C. Tian, J. Risinger, C.L. Brown, G.S. Rose, and J.T. Thigpen Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma: a Gynecologic Oncology Group study Cancer 107 9 Nov. 1 2006 2197 2205 (Pubitemid 44665654)
25. M.E. Sherman, J.D. Carreon, J.V. Lacey Jr., and S.S. Devesa Impact of hysterectomy on endometrial carcinoma rates in the United States J Natl Cancer Inst 97 22 Nov. 16 2005 1700 1702 (Pubitemid 41672237)
26. J.H. Farley, C. Tian, G.S. Rose, C.L. Brown, M. Birrer, and J.I. Risinger Chemotherapy intensity and toxicity among black and white women with advanced and recurrent endometrial cancer: a Gynecologic Oncology Group Study Cancer 116 2 Jan. 15 2010 355 361
27. S.E. Ferguson, A.B. Olshen, D.A. Levine, A. Viale, R.R. Barakat, and J. Boyd Molecular profiling of endometrial cancers from African-American and Caucasian women Gynecol Oncol 101 2 May 2006 209 213
28. M.H. Einstein, D.M. Kushner, J.P. Connor, A.A. Bohl, T.J. Best, and M.D. Evans A protocol of dual prophylaxis for venous thromboembolism prevention in gynecologic cancer patients Obstet Gynecol 112 5 Nov. 2008 1091 1097
29. M. Arafa, J. Somja, P. Dehan, F. Kridelka, F. Goffin, and J. Boniver Current concepts in the pathology and epigenetics of endometrial carcinoma Pathology 42 7 Dec. 2010 613 617
30. E.R. Kost, K.L. Hall, J.F. Hines, J.H. Farley, L.R. Nycum, and G.S. Rose Asian-Pacific Islander race independently predicts poor outcome in patients with endometrial cancer Gynecol Oncol 89 2 May 2003 218 226 (Pubitemid 36457868)
31. K. Zhu, S.S. Devesa, H. Wu, S.H. Zahm, I. Jatoi, and W.F. Anderson Cancer incidence in the U.S. military population: comparison with rates from the SEER program Cancer Epidemiol Biomarkers Prev 18 6 Jun. 2009 1740 1745 [Comparative Study: Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.]
32. C.H.P.S. Johnson, P. Adamo, A. Fritz, A. Percy-Laurry, and E. BK The multiple primary and histology coding rules 2007 National Cancer Institute Bethesda MD 2007
33. The North American Association Of Central Cancer Registries Report of the Automated Tumor Linkage work group of the ROC Available from http://www.naaccr.org/index.asp?Col-SectionKey=28&Col-ContentID=433 October 2005
34. J.H. Farley, L.R. Nycum, M.J. Birrer, R.C. Park, and R.R. Taylor Age-specific survival of women with endometrioid adenocarcinoma of the uterus Gynecol Oncol 79 1 2000 Oct 86 89
35. World Health Organization International classification of diseases for oncology 1976 World Health Organization Geneva
36. C.V. Percy, and C. Muir International classification of diseases for oncology 2nd ed. 1990 World Health Organization Geneva
37. A.J.A.S.K. Fritz International classification of disease for oncology 3rd ed. 2000 World Health Organization Geneva
38. K.E. Oliver, and J.H. Farley Deciphering surveillance, epidemiology, and end results data analysis: are we seeing the whole picture? Cancer Mar. 8 2011 Epub ahead of print
39. F.L. Brancati, W.H. Kao, A.R. Folsom, R.L. Watson, and M. Szklo Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study JAMA 283 17 May 3 2000 2253 2259 (Pubitemid 30246776)
40. A.S. Felix, J.L. Weissfeld, R.A. Stone, R. Bowser, M. Chivukula, and R.P. Edwards Factors associated with type i and type II endometrial cancer Cancer Causes Control 21 11 Nov. 2010 1851 1856
41. J.V. Bokhman Two pathogenetic types of endometrial carcinoma Gynecol Oncol 15 1 Feb. 1983 10 17 (Pubitemid 13194678)
42. T.R. Rebbeck, A.B. Troxel, Y. Wang, A.H. Walker, S. Panossian, and S. Gallagher Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk J Natl Cancer Inst 98 18 Sep. 20 2006 1311 1320 (Pubitemid 44530726)
43. M. Zahid, E. Kohli, M. Saeed, E. Rogan, and E. Cavalieri The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity Chem Res Toxicol 19 1 Jan 2006 164 172 (Pubitemid 43185475)
44. B.C. Lin, M. Suzawa, R.D. Blind, S.C. Tobias, S.E. Bulun, and T.S. Scanlan Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation Cancer Res 69 13 Jul. 1 2009 5415 5423
45. S. Saini, H. Hirata, S. Majid, and R. Dahiya Functional significance of cytochrome P450 1B1 in endometrial carcinogenesis Cancer Res 69 17 Sep. 1 2009 7038 7045
46. T. Sliwinski, P. Sitarek, T. Stetkiewicz, A. Sobczuk, and J. Blasiak Polymorphism of the ERalpha and CYP1B1 genes in endometrial cancer in a Polish subpopulation J Obstet Gynaecol Res 36 2 Apr. 2010 311 317
47. L.R. Bailey, N. Roodi, W.D. Dupont, and F.F. Parl Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer Cancer Res 58 22 Nov. 15 1998 5038 5041 (Pubitemid 28521155)
48. V. Rosato, A. Zucchetto, C. Bosetti, L. Dal Maso, M. Montella, and C. Pelucchi Metabolic syndrome and endometrial cancer risk Annals of oncology: official journal of the European Society for Medical Oncology/ESMO 22(4) Apr. 2011 884 889
49. A.N. Scholten, V.T. Smit, H. Beerman, W.L. van Putten, and C.L. Creutzberg Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma Cancer 100 4 Feb. 15 2004 764 772 [Comparative Study]. (Pubitemid 38176855)